Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries
This study aimed to estimate the return on investments of three population-level tobacco cessation strategies and three pharmacological interventions. The analysis included 124 low- and middle-income countries, and assumed a 10-year investment period (2021–2030). The results indicate that all six ce...
Published in: | Revista Panamericana de Salud Pública |
---|---|
Main Authors: | , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English Spanish Portuguese |
Published: |
Pan American Health Organization
2022
|
Subjects: | |
Online Access: | https://doi.org/10.26633/RPSP.2022.71 https://doaj.org/article/eb5f98cf63b8485483ab8637fe042958 |
id |
ftdoajarticles:oai:doaj.org/article:eb5f98cf63b8485483ab8637fe042958 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:eb5f98cf63b8485483ab8637fe042958 2023-05-15T15:13:27+02:00 Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries Guillermo A. Sandoval Robert Totanes Annette M. David Dongbo Fu Douglas Bettcher Vinayak Prasad Virginia Arnold 2022-10-01T00:00:00Z https://doi.org/10.26633/RPSP.2022.71 https://doaj.org/article/eb5f98cf63b8485483ab8637fe042958 EN ES PT eng spa por Pan American Health Organization https://iris.paho.org/handle/10665.2/56447 https://doaj.org/toc/1020-4989 https://doaj.org/toc/1680-5348 1020-4989 1680-5348 doi:10.26633/RPSP.2022.71 https://doaj.org/article/eb5f98cf63b8485483ab8637fe042958 Revista Panamericana de Salud Pública, Vol 46, Iss 71, Pp 1-6 (2022) tobacco use cessation investment cost-benefit analysis developing countries Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2022 ftdoajarticles https://doi.org/10.26633/RPSP.2022.71 2022-12-30T19:53:29Z This study aimed to estimate the return on investments of three population-level tobacco cessation strategies and three pharmacological interventions. The analysis included 124 low- and middle-income countries, and assumed a 10-year investment period (2021–2030). The results indicate that all six cessation programmes could help about 152 million tobacco users quit and save 2.7 million lives during 2021–2030. If quitters were followed until 65 years of age, 16 million lives could be saved from quitting. The combined investment cost was estimated at 1.68 United States dollars (US$) per capita a year, or US$ 115 billion over the period 2021–2030, with Caribbean countries showing the lowest investment cost at US$ 0.50 per capita a year. Return on investments was estimated at 0.79 (at the end of 2030) and 7.50 if benefits were assessed by the time quitters reach the age of 65 years. Disaggregated results by country income level and region also showed a return on investments less than 1.0 in the short term and greater than 1.0 in the medium-to-long term. In all countries, population-level interventions were less expensive and yielded a return on investments greater than 1.0 in the short and long term, with investment cost estimated at US$ 0.21 per capita a year, or US$ 14.3 billion over 2021–2030. Pharmacological interventions were more expensive and became cost beneficial over a longer time. These results are likely conservative and provide support for a phased approach implementing population-level strategies first, where most countries would reach break-even before 2030. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Revista Panamericana de Salud Pública 46 1 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English Spanish Portuguese |
topic |
tobacco use cessation investment cost-benefit analysis developing countries Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
tobacco use cessation investment cost-benefit analysis developing countries Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Guillermo A. Sandoval Robert Totanes Annette M. David Dongbo Fu Douglas Bettcher Vinayak Prasad Virginia Arnold Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries |
topic_facet |
tobacco use cessation investment cost-benefit analysis developing countries Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
This study aimed to estimate the return on investments of three population-level tobacco cessation strategies and three pharmacological interventions. The analysis included 124 low- and middle-income countries, and assumed a 10-year investment period (2021–2030). The results indicate that all six cessation programmes could help about 152 million tobacco users quit and save 2.7 million lives during 2021–2030. If quitters were followed until 65 years of age, 16 million lives could be saved from quitting. The combined investment cost was estimated at 1.68 United States dollars (US$) per capita a year, or US$ 115 billion over the period 2021–2030, with Caribbean countries showing the lowest investment cost at US$ 0.50 per capita a year. Return on investments was estimated at 0.79 (at the end of 2030) and 7.50 if benefits were assessed by the time quitters reach the age of 65 years. Disaggregated results by country income level and region also showed a return on investments less than 1.0 in the short term and greater than 1.0 in the medium-to-long term. In all countries, population-level interventions were less expensive and yielded a return on investments greater than 1.0 in the short and long term, with investment cost estimated at US$ 0.21 per capita a year, or US$ 14.3 billion over 2021–2030. Pharmacological interventions were more expensive and became cost beneficial over a longer time. These results are likely conservative and provide support for a phased approach implementing population-level strategies first, where most countries would reach break-even before 2030. |
format |
Article in Journal/Newspaper |
author |
Guillermo A. Sandoval Robert Totanes Annette M. David Dongbo Fu Douglas Bettcher Vinayak Prasad Virginia Arnold |
author_facet |
Guillermo A. Sandoval Robert Totanes Annette M. David Dongbo Fu Douglas Bettcher Vinayak Prasad Virginia Arnold |
author_sort |
Guillermo A. Sandoval |
title |
Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries |
title_short |
Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries |
title_full |
Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries |
title_fullStr |
Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries |
title_full_unstemmed |
Case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries |
title_sort |
case for investment in tobacco cessation: a population-based analysis in low- and middle-income countries |
publisher |
Pan American Health Organization |
publishDate |
2022 |
url |
https://doi.org/10.26633/RPSP.2022.71 https://doaj.org/article/eb5f98cf63b8485483ab8637fe042958 |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Revista Panamericana de Salud Pública, Vol 46, Iss 71, Pp 1-6 (2022) |
op_relation |
https://iris.paho.org/handle/10665.2/56447 https://doaj.org/toc/1020-4989 https://doaj.org/toc/1680-5348 1020-4989 1680-5348 doi:10.26633/RPSP.2022.71 https://doaj.org/article/eb5f98cf63b8485483ab8637fe042958 |
op_doi |
https://doi.org/10.26633/RPSP.2022.71 |
container_title |
Revista Panamericana de Salud Pública |
container_volume |
46 |
container_start_page |
1 |
_version_ |
1766344014029651968 |